Tonix Pharmaceuticals Holding (TNXP) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$190.1 million.
- Tonix Pharmaceuticals Holding's Enterprise Value fell 57316.62% to -$190.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.1 million, marking a year-over-year decrease of 57316.62%. This contributed to the annual value of -$98.8 million for FY2024, which is 29592.75% down from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Enterprise Value is -$190.1 million, which was down 57316.62% from -$125.3 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Enterprise Value high stood at -$4.2 million for Q2 2024, and its period low was -$190.1 million during Q3 2025.
- For the 3-year period, Tonix Pharmaceuticals Holding's Enterprise Value averaged around -$65.0 million, with its median value being -$28.2 million (2024).
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Enterprise Value surged by 9020.63% in 2024 and then tumbled by 291566.41% in 2025.
- Tonix Pharmaceuticals Holding's Enterprise Value (Quarter) stood at -$24.9 million in 2023, then plummeted by 295.93% to -$98.8 million in 2024, then tumbled by 92.41% to -$190.1 million in 2025.
- Its Enterprise Value stands at -$190.1 million for Q3 2025, versus -$125.3 million for Q2 2025 and -$131.7 million for Q1 2025.